Your browser doesn't support javascript.
loading
Symptom-based staging for logopenic variant primary progressive aphasia.
Hardy, Chris J D; Taylor-Rubin, Cathleen; Taylor, Beatrice; Harding, Emma; Gonzalez, Aida Suarez; Jiang, Jessica; Thompson, Laura; Kingma, Rachel; Chokesuwattanaskul, Anthipa; Walker, Ffion; Barker, Suzie; Brotherhood, Emilie; Waddington, Claire; Wood, Olivia; Zimmermann, Nikki; Kupeli, Nuriye; Yong, Keir X X; Camic, Paul M; Stott, Joshua; Marshall, Charles R; Oxtoby, Neil P; Rohrer, Jonathan D; O'Shea, Frankie; Volkmer, Anna; Crutch, Sebastian J; Warren, Jason D.
Affiliation
  • Hardy CJD; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Taylor-Rubin C; Uniting War Memorial Hospital, Sydney, New South Wales, Australia.
  • Taylor B; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
  • Harding E; UCL Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK.
  • Gonzalez AS; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Jiang J; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Thompson L; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Kingma R; Uniting War Memorial Hospital, Sydney, New South Wales, Australia.
  • Chokesuwattanaskul A; Uniting War Memorial Hospital, Sydney, New South Wales, Australia.
  • Walker F; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Barker S; Division of Neurology, Department of Internal Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
  • Brotherhood E; Cognitive Clinical and Computational Neuroscience Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Waddington C; HealthAbility, Melbourne, Victoria, Australia.
  • Wood O; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Zimmermann N; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Kupeli N; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Yong KXX; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Camic PM; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Stott J; Division of Psychiatry, Marie Curie Palliative Care Research Department, UCL, London, UK.
  • Marshall CR; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Oxtoby NP; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Rohrer JD; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • O'Shea F; ADAPTlab, Research Department of Clinical, Educational and Health Psychology, UCL, London, UK.
  • Volkmer A; Centre for Preventive Neurology, Queen Mary University of London, London, UK.
  • Crutch SJ; UCL Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK.
  • Warren JD; Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Eur J Neurol ; 31(7): e16304, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38666798
ABSTRACT
BACKGROUND AND

PURPOSE:

Logopenic variant primary progressive aphasia (lvPPA) is a major variant presentation of Alzheimer's disease (AD) that signals the importance of communication dysfunction across AD phenotypes. A clinical staging system is lacking for the evolution of AD-associated communication difficulties that could guide diagnosis and care planning. Our aim was to create a symptom-based staging scheme for lvPPA, identifying functional milestones relevant to the broader AD spectrum.

METHODS:

An international lvPPA caregiver cohort was surveyed on symptom development under an 'exploratory' survey (34 UK caregivers). Feedback from this survey informed the development of a 'consolidation' survey (27 UK, 10 Australian caregivers) in which caregivers were presented with six provisional clinical stages and feedback was analysed using a mixed-methods approach.

RESULTS:

Six clinical stages were endorsed. Early symptoms included word-finding difficulty, with loss of message comprehension and speech intelligibility signalling later-stage progression. Additionally, problems with hearing in noise, memory and route-finding were prominent early non-verbal symptoms. 'Milestone' symptoms were identified that anticipate daily-life functional transitions and care needs.

CONCLUSIONS:

This work introduces a new symptom-based staging scheme for lvPPA, and highlights milestone symptoms that could inform future clinical scales for anticipating and managing communication dysfunction across the AD spectrum.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aphasia, Primary Progressive Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2024 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aphasia, Primary Progressive Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2024 Document type: Article Affiliation country: United kingdom
...